The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / C•••• C•••••• H••••••••• L••••• D•••••••

A•• S••• H••••••••• S•••••••• Acquires C•••• C•••••• H••••••••• L••••• D•••••••

Add-on acquisitionannouncedadd-onannounced Jul 28, 2026Fact
What happened
Platform
A•• S••• H••••••••• S••••••••add-on basis: All S••• is a portfolio company of K••• L•••.
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • J••• B•••••Deal partnerconfirmed
    "Positioning the locums division within A•• S••• H••••••••• S•••••••• creates a more robust platform with enhanced capabilities that is built for long-term growth," said J••• B•••••, Managing Partner at K••• L•••, and Shamik Patel, Partner at K••• L•••.
  • All S••• is a portfolio company of K••• L•••.
  • All S••• is a portfolio company of K••• L•••.
Side not stated
  • "C•••• C•••••• H••••••••• locums business brings an established client base, an experienced team, and a strong record of service," said K•• B••••••••, Chief Executive Officer of A•• S••• H••••••••• S••••••••.
  • "The locums division has served clients and physicians with excellence for many years, and A•• S••• H••••••••• S•••••••• is the right home to build on its foundation and support its next phase of growth," said J••• T•••••••, Chief Executive Officer of C•••• C•••••• H•••••••••.
  • A•• S••• H••••••••• S•••••••• Acquires C•••• C•••••• H••••••••• L••••• D•••••••
Evidence
A•• S••• H••••••••• S•••••••• Acquires C•••• C•••••• H••••••••• L••••• D•••••••
A•• S••• H••••••••• S•••••••• Acquires C•••• C•••••• H••••••••• L••••• D••••••• | Private Equity Intelligence | DFX